<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this study we investigated the frequency and the type of manifestations of antiprothrombin antibodies (aFII) in patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>In 16 (84.2%) of 19 patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) and either anticardiolipin antibodies or antiphosphatidylserine antibodies, two types of abnormal patterns were shown on a crossed immuno-electrophoresis technique using anti-human prothrombin murine IgG </plain></SENT>
<SENT sid="2" pm="."><plain>The slow-moving peak of prothrombin was detected in 8 patients, while a peak in the other patients had the slow-moving shoulder </plain></SENT>
<SENT sid="3" pm="."><plain>These slow-moving materials might represent prothrombin-aFII complexes </plain></SENT>
<SENT sid="4" pm="."><plain>In 13 patients who were studied on Western blots, IgGs of 11 patients (84 </plain></SENT>
<SENT sid="5" pm="."><plain>6%) bound to human purified prothrombin, and the IgGs of 7 (53.8%) of these patients also bound to human purified alpha-thrombin </plain></SENT>
<SENT sid="6" pm="."><plain>Our results indicate that aFII detected in patients with APS may explain part of the mechanism of LA </plain></SENT>
</text></document>